GSA Capital Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
630,809
-132,121
| -17% | -$300K | 0.1% | 250 |
|
|
2025
Q1 | $485K | Buy |
762,930
+724,045
| +1,862% | +$460K | 0.04% | 827 |
|
|
2024
Q4 | $40K | Buy |
+38,885
| New | +$40K | ﹤0.01% | 1542 |
|
|
2024
Q3 | – | Sell |
-229,093
| Closed | -$279K | – | 1660 |
|
|
2024
Q2 | $279K | Buy |
229,093
+80,526
| +54% | +$98.1K | 0.02% | 1311 |
|
|
2024
Q1 | $324K | Buy |
148,567
+44,405
| +43% | +$96.8K | 0.03% | 1169 |
|
|
2023
Q4 | $161K | Buy |
+104,162
| New | +$161K | 0.01% | 1362 |
|
|
2023
Q3 | – | Sell |
-344,169
| Closed | -$592K | – | 1558 |
|
|
2023
Q2 | $592K | Buy |
+344,169
| New | +$592K | 0.06% | 641 |
|
|
2021
Q4 | – | Sell |
-249,146
| Closed | -$1.27M | – | 1460 |
|
|
2021
Q3 | $1.27M | Buy |
+249,146
| New | +$1.27M | 0.13% | 194 |
|
|
2021
Q2 | – | Sell |
-19,093
| Closed | -$148K | – | 1355 |
|
|
2021
Q1 | $148K | Sell |
19,093
-12,761
| -40% | -$98.9K | 0.02% | 959 |
|
|
2020
Q4 | $209K | Buy |
31,854
+3,603
| +13% | +$23.6K | 0.03% | 963 |
|
|
2020
Q3 | $188K | Sell |
28,251
-12,484
| -31% | -$83.1K | 0.03% | 1024 |
|
|
2020
Q2 | $339K | Sell |
40,735
-20,681
| -34% | -$172K | 0.19% | 148 |
|
|
2020
Q1 | $471K | Sell |
61,416
-55,100
| -47% | -$423K | 0.12% | 195 |
|
|
2019
Q4 | $968K | Buy |
116,516
+38,519
| +49% | +$320K | 0.11% | 233 |
|
|
2019
Q3 | $576K | Buy |
77,997
+12,302
| +19% | +$90.8K | 0.08% | 461 |
|
|
2019
Q2 | $737K | Buy |
65,695
+30,037
| +84% | +$337K | 0.08% | 416 |
|
|
2019
Q1 | $383K | Buy |
35,658
+958
| +3% | +$10.3K | 0.04% | 853 |
|
|
2018
Q4 | $524K | Sell |
34,700
-200
| -0.6% | -$3.02K | 0.06% | 534 |
|
|
2018
Q3 | $646K | Sell |
34,900
-15,100
| -30% | -$280K | 0.04% | 946 |
|
|
2018
Q2 | $1.14M | Buy |
50,000
+41,167
| +466% | +$941K | 0.06% | 664 |
|
|
2018
Q1 | $251K | Buy |
+8,833
| New | +$251K | 0.01% | 1384 |
|